Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 360 entries
View as:

Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2

Phase: N/A Priority: Normal
NCT ID: NCT00019812 Org: User:
Start: 08/31/99 End: 02/29/04 Due: 02/28/05

Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins

Phase: N/A Priority: Normal
NCT ID: NCT00055159 Org: User:
Start: 02/19/03 End: 12/10/07 Due: 12/10/08

Characteristics and Outcomes of a Capacity-to-Consent Assessment Service

Phase: N/A Priority: Normal
NCT ID: NCT03258606 Org: User:
Start: 06/26/17 End: 04/09/21 Due: 04/09/22

Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products

Phase: N/A Priority: Normal
NCT ID: NCT01071577 Org: User:
Start: 03/17/10 End: 08/07/18 Due: 08/07/19

Iron Replacement in Blood Donors

Phase: N/A Priority: Normal
NCT ID: NCT00327067 Org: User:
Start: 05/12/06 End: 03/01/12 Due: 03/01/13

Problem-Solving Education for Caregivers and Patients During Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00766883 Org: User:
Start: 09/29/08 End: 12/15/10 Due: 12/15/11

Mild Traumatic Brain Injury and Post-Traumatic Stress Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01547819 Org: User:
Start: 02/16/12 End: 12/18/13 Due: 12/18/14

Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT05170412 Org: User:
Start: 05/26/22 End: 12/31/26 Due: 12/31/27

Research Participant Perception of Care Project: Part II: Fielding and Validation of the Research Participant Perception Survey Derived From Focus Group-Identified Key Dimensions of the Research Participant Experience

Phase: N/A Priority: Normal
NCT ID: NCT01129869 Org: User:
Start: 05/13/10 End: 02/01/18 Due: 02/01/19

Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00019643 Org: User:
Start: 08/31/99 End: 04/30/07 Due: 04/30/08

Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis From Existing Radiologic Images

Phase: N/A Priority: Normal
NCT ID: NCT04579237 Org: User:
Start: 10/05/20 End: 06/30/30 Due: 06/30/31

Magnetic Resonance Angiography (MRA) for the Diagnosis of Atherosclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00001841 Org: User:
Start: 03/31/99 End: 12/31/04 Due: 12/31/05

A Clinical Trial of a Gamified Attention Bias Modification Training in Anxious Youth

Phase: N/A Priority: Normal
NCT ID: NCT03283930 Org: User:
Start: 11/01/16 End: 09/01/23 Due: 09/01/24

Imaging Characterization of the Biomechanical Coupling of Brain and Skull

Phase: N/A Priority: Normal
NCT ID: NCT05675423 Org: User:
Start: 09/12/24 End: 09/12/24 Due: 09/12/25

Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV

Phase: N/A Priority: Normal
NCT ID: NCT00004846 Org: User:
Start: 12/31/99 End: 10/31/02 Due: 10/31/03

Leucovorin for the Treatment of 5 q Minus Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00004997 Org: User:
Start: 04/30/98 End: 07/31/02 Due: 07/31/03

Web-based Patient Reported Outcome Measurement Information System (PROMIS ) to Explore Burden and Stress in Cancer Caregivers (BaSiC2)

Phase: N/A Priority: Normal
NCT ID: NCT01981538 Org: User:
Start: 11/07/13 End: 08/23/16 Due: 08/23/17

Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00589381 Org: User:
Start: 08/31/07 End: 03/31/11 Due: 03/31/12

Point Prevalence Study of Multidrug-Resistant Organism Carriage by Healthcare Personnel

Phase: N/A Priority: Normal
NCT ID: NCT01952158 Org: User:
Start: 09/13/13 End: 01/13/17 Due: 01/13/18

Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infections

Phase: N/A Priority: Normal
NCT ID: NCT06126263 Org: User:
Start: 01/01/23 End: 06/30/24 Due: 06/30/25

Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00078494 Org: User:
Start: 02/29/04 End: 05/31/06 Due: 05/31/07

Evaluation of Patients With Critical Illness

Phase: N/A Priority: Normal
NCT ID: NCT00100217 Org: User:
Start: 12/21/04 End: 06/25/10 Due: 06/25/11

The Natural History of Upper Trapezius Myofascial Trigger Points: Comparison of Local and Remote Tissue Milieu in Normal Muscle, Latent and Active Myofascial Trigger Points Over Time

Phase: N/A Priority: Normal
NCT ID: NCT00042276 Org: User:
Start: 07/14/02 End: 03/15/13 Due: 03/15/14

Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00093444 Org: User:
Start: 09/30/04 End: 01/31/10 Due: 01/31/11

Role of Prostaglandins in the Regulation of Brain Blood Flow

Phase: N/A Priority: Normal
NCT ID: NCT00006318 Org: User:
Start: 09/30/00 End: 12/31/03 Due: 12/31/04